BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹14,334 Cr | ₹15,359 Cr | ₹8,511 Cr | ₹3,828 Cr | ₹4,210 Cr |
What is the latest Total Current Liabilities ratio of BIOCON ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹14,334 Cr |
| Mar2024 | ₹15,359 Cr |
| Mar2023 | ₹8,511 Cr |
| Mar2022 | ₹3,828 Cr |
| Mar2021 | ₹4,210 Cr |
How is Total Current Liabilities of BIOCON Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,334 Cr | -6.67 | |
| Mar2024 | ₹15,359 Cr | 80.46 | |
| Mar2023 | ₹8,511 Cr | 122.33 | |
| Mar2022 | ₹3,828 Cr | -9.08 | |
| Mar2021 | ₹4,210 Cr | - | |
Compare Total Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹56,504.6 Cr | -1.8% | -10.6% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.8% |
-10.6% |
0.1% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses